Kanglexin delays heart aging by promoting mitophagy
Authors:
- 25 May 2021
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 43 (3) , 613-623
Abstract
Heart aging is characterized by structural and diastolic dysfunction of the heart. However, there is still no effective drug to prevent and treat the abnormal changes in cardiac function caused by aging. Here, we present the preventive effects of emodin and its derivative Kanglexin (KLX) against heart aging. We found that the diastolic dysfunction and cardiac remodeling in mice with D-galactose (D-gal)-induced aging were markedly mitigated by KLX and emodin. In addition, the senescence of neonatal mouse cardiomyocytes induced by D-gal was also reversed by KLX and emodin treatment. However, KLX exhibited better anti-heart aging effects than emodin at the same dose. Dysregulated mitophagy was observed in aging hearts and in senescent neonatal mouse cardiomyocytes, and KLX produced a greater increase in mitophagy than emodin. The mitophagy-promoting effects of KLX and emodin were ascribed to their abilities to enhance the protein stability of Parkin, a key modulator in mitophagy, with different potencies. Molecular docking and SPR analysis demonstrated that KLX has a higher affinity for the ubiquitin-like (UBL) domain of Parkin than emodin. The UBL domain might contribute to the stabilizing effects of KLX on Parkin. In conclusion, this study identifies KLX and emodin as effective anti-heart aging drugs that activate Parkin-mediated mitophagy and outlines their putative therapeutic importance.Keywords
This publication has 60 references indexed in Scilit:
- Age As a Risk FactorMedical Clinics of North America, 2012
- Autoregulation of Parkin activity through its ubiquitin‐like domainThe EMBO Journal, 2011
- Inhibition of autophagy in the heart induces age-related cardiomyopathyAutophagy, 2010
- PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate ParkinPLOS Biology, 2010
- Differential Interaction of the E3 Ligase Parkin with the Proteasomal Subunit S5a and the Endocytic Protein Eps15Journal of Biological Chemistry, 2010
- Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogasterCell Metabolism, 2010
- Protective effect of long-term angiotensin II inhibitionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interactionAntiviral Research, 2007
- A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K–Akt signallingNature Cell Biology, 2006
- Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease EnterprisesCirculation, 2003